Global FPI for MAC in Atopic Dermatitis Trial
Ziarco Initiates Phase 2a Clinical Trial of ZPL-389 in Atopic Dermatitis.
MAC Clinical Research is a full-service, global, pharmaceutical contract research organization (CRO), with science at the heart of everything we do. Read More…
Effective solutions to successfully deliver your clinical trials.
MAC conduct clinical trials for most of the worlds leading pharma and biotechs. Read More…
We offer an array of scientific solutions to support any clinical trial. Read More…
MAC’s flexible strategic consulting can support your project at any stage. Read More…
Ziarco Initiates Phase 2a Clinical Trial of ZPL-389 in Atopic Dermatitis.
Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |